METHOD OF TROPHOBLASTIC BETA-1-GLYCOPROTEIN RELEASE AND PURIFICATION

FIELD: medicine; chemistry-pharmaceutical industry. ^ SUBSTANCE: trophoblastic beta-1-glycoprotein is released from serosity produced as a result of differential centrifugation of retroplacental human blood. Supernatant after first centrifugation is saturated with sodium chloride (0.1-1.0 mole/l) to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SHMAGEL' KONSTANTIN VLADIMIROVICH, DEMAKOV VITALIJ ALEKSEEVICH, RAEV MIKHAIL BORISOVICH, CHERESHNEV VALERIJ ALEKSANDROVICH, RAEV ALEKSANDR BORISOVICH, BAKHMET'EV BORIS ARKAD'EVICH
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: medicine; chemistry-pharmaceutical industry. ^ SUBSTANCE: trophoblastic beta-1-glycoprotein is released from serosity produced as a result of differential centrifugation of retroplacental human blood. Supernatant after first centrifugation is saturated with sodium chloride (0.1-1.0 mole/l) to prevent non-specific sorption and centrifuged once more with triton X-100 (0.01-0.05%) to virus inactivation. Then it is applied to affine sorbent that is sepharose with solid-phase monoclonal antibodies to trophoblastic beta-1-glycoprotein. Protein is eluated with 0.1 M glycine-HCI buffer solution, and after neutralization and in-depth analysis second affine chromatography is carried out on sepharose with modified protein G, released from streptococcus cell wall to prevent immunoglobulin contamination. Solution passed through column and trophoblastic beta-1-glycoprotein is been concentrating and dialyzing from saline and lyophilized. ^ EFFECT: increased output and purity of end product. ^ 2 ex